Search research articles
Contact Us
Filters
Showing results (91-100 of 601) with videos related to
Page
of 61
Sort By:
Journal of Neurology
|
November 19, 2009
Development of oral cladribine for the treatment of multiple sclerosis
Hans-Peter Hartung, Orhan Aktas, Bernd Kieseier, et al.
Neuropharmacology
|
October 22, 2008
Neural precursor cells as a novel target for interferon-beta
Jennifer Wellen, Janine Walter, Parastoo Jangouk, et al.
The Lancet. Neurology
|
June 21, 2005
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis
Bernhard Hemmer, Olaf Stüve, Bernd Kieseier, et al.
Brain and Behavior
|
July 22, 2021
Type O blood group associates with higher anti-JC polyomavirus antibody levels
Pia Frenken, Hans-Peter Hartung, Tomas Olsson, et al.
Biochimica Et Biophysica Acta
|
February 10, 2015
Redox-regulated fate of neural stem progenitor cells
Tim Prozorovski, Reiner Schneider, Carsten Berndt, et al.
Therapeutic Advances in Neurological Disorders
|
July 2, 2016
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies
Verena I Leussink, Hans-Peter Hartung, Bernd C Kieseier, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
Nik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Journal of Neuroinflammation
|
July 20, 2020
Comparison of different optomotor response readouts for visual testing in experimental autoimmune encephalomyelitis-optic neuritis
Christina Hecker, Michael Dietrich, Andrea Issberner, et al.
Der Nervenarzt
|
June 12, 2020
[Ocrelizumab for treatment of multiple sclerosis]
Jonas Graf, Philipp Albrecht, Norbert Goebels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 31, 2004
Osteopontin, a macrophage-derived matricellular glycoprotein, inhibits axon outgrowth
Patrick Küry, Philipp Zickler, Guido Stoll, et al.
Page
of 61
Search research articles
Search
Showing results (91-100 of 601) with videos related to
Sort By:
Page
of 61
Journal of Neurology
|
November 19, 2009
Development of oral cladribine for the treatment of multiple sclerosis
Hans-Peter Hartung, Orhan Aktas, Bernd Kieseier, et al.
Neuropharmacology
|
October 22, 2008
Neural precursor cells as a novel target for interferon-beta
Jennifer Wellen, Janine Walter, Parastoo Jangouk, et al.
The Lancet. Neurology
|
June 21, 2005
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis
Bernhard Hemmer, Olaf Stüve, Bernd Kieseier, et al.
Brain and Behavior
|
July 22, 2021
Type O blood group associates with higher anti-JC polyomavirus antibody levels
Pia Frenken, Hans-Peter Hartung, Tomas Olsson, et al.
Biochimica Et Biophysica Acta
|
February 10, 2015
Redox-regulated fate of neural stem progenitor cells
Tim Prozorovski, Reiner Schneider, Carsten Berndt, et al.
Therapeutic Advances in Neurological Disorders
|
July 2, 2016
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies
Verena I Leussink, Hans-Peter Hartung, Bernd C Kieseier, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
Nik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Journal of Neuroinflammation
|
July 20, 2020
Comparison of different optomotor response readouts for visual testing in experimental autoimmune encephalomyelitis-optic neuritis
Christina Hecker, Michael Dietrich, Andrea Issberner, et al.
Der Nervenarzt
|
June 12, 2020
[Ocrelizumab for treatment of multiple sclerosis]
Jonas Graf, Philipp Albrecht, Norbert Goebels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 31, 2004
Osteopontin, a macrophage-derived matricellular glycoprotein, inhibits axon outgrowth
Patrick Küry, Philipp Zickler, Guido Stoll, et al.
Page
of 61